In CeD the adaptive immune response is triggered by antigen-presenting cells (APC) that transport gluten peptides to CD4+ T cells, resulting in increased production and release of pro-inflammatory cytokines. The gene discussed is CD4; the disease is cranioectodermal dysplasia.